In today’s Pharmaceutical Executive Daily, MJH Life Sciences CEO, Mike Hennessy Jr. examines why pharma and medtech still ...

The US Department of Health and Human Services (HHS) issued new guidance clarifying how pharmaceutical manufacturers can ...

Public Citizen filed a lawsuit against the Trump administration in the U.S. District Court for the District of Columbia ...

Tenpoint Therapeutics announced FDA’s approval of Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% ...

PE: After presenting topline results from Phase 3 trials, what's next for Varegacestat? Siegall: We presented topline data.

Gavi, the Vaccine Alliance, is a group that describes itself as being focused on improving access to vaccines for children living in the world’s poorest countries. While the United States previously ...

PE: What key learnings did your team learn during launch? Skalicky: Three things come to mind. First, integration beats ...

If you want the cleanest case study of pharma and diagnostics actually operating as one strategic engine, it’s Roche. Roche ...

In today’s Pharmaceutical Executive Daily, Insilico Medicine and Qilu Pharmaceuticals launch a $120 million collaboration to advance AI-driven cardiometabolic therapies, Eli Lilly enters a ...

FDA approved Darzalex Faspro (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide, and dexamethasone for the treatment of adult patients with newly diagnosed multiple ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

Insilico Medicine and Qilu Pharmaceutical Group announced a strategic collaboration to jointly develop small-molecule inhibitors for cardiometabolic diseases, combining Insilico’s generative AI–driven ...